Apcotex Industries Ltd

- The company currently has a healthy balance sheet with low debt, net borrowings around Rs. 90 crores against a turnover of Rs. 1400 crores. - Management is not worried about the balance sheet and sees it as strong. - They may consider taking on additional debt for future expansion plans, as the balance sheet can easily support it. - No specific plans or decisions have been made yet regarding new fundraising through debt or equity. - Any significant updates on capital expenditure or fundraising will be communicated to investors and analysts in due course. - The company is also exploring potential acquisition or partnership opportunities for growth, which may influence future funding needs.

- There will certainly be some growth CAPEX in the next few quarters (5-6 quarters), as current capacities, especially nitrile latex, are expected to be fully utilized soon. - Planning for various CAPEX options is underway, but no final decisions have been made or triggers pulled yet. - The company will inform investors and analysts when there are significant updates on expansion plans. - Minor investments are expected to enable achieving around Rs. 1700 crores revenue, with further capacity expansions potentially pushing this higher. - The company is also actively exploring acquisition or partnership opportunities that could contribute to future growth. - Balance sheet is healthy, with capacity to take on more debt if needed for future expansion. - No specific timelines given, but clarity on expansion plans is expected within 3 to 6 months.

- The company expects total revenue to reach around Rs. 1,700 crores at full current capacity, with potential to increase to Rs. 1,800-1,900 crores with further capacity utilization and minor investments. - Export sales constitute one-third of current revenue and are expected to grow faster than domestic sales, potentially reaching 42-45% of total revenue over the next couple of years. - Volume growth has been strong with record highs in recent quarters, but the company anticipates that such high growth rates (e.g., 35% export growth YTD) may not be sustainable going forward. - Growth is driven by nitrile latex and other latex products, though the latter's margins are currently low but expected to improve gradually. - The company plans some growth CAPEX within the next 5-6 quarters to meet full capacity utilization and is exploring acquisition/partnership opportunities to further growth. - Domestic growth continues with expansion into new geographies and markets.

- Revenue is expected to reach around Rs. 1,700 to Rs. 1,900 crores at full capacity, from about Rs. 1,400-1,450 crores currently. - Exports, currently 33% of revenue, are projected to grow to 42-45% over the next couple of years, supporting faster overall growth. - Capacity utilization improvements, especially in nitrile latex and paper segments, should enhance margins. - Margins expected to improve gradually as capacity utilization rises and anti-dumping duties take effect. - Specialty product segments with higher margins (10-20% of revenue) are being emphasized to improve overall profitability. - EBITDA margins likely to rebound from recent dips (currently around 7.6-8.3%) with operational efficiencies and pricing power recovery. - Profit after tax growth expected along with gradual EBITDA margin expansion; company confident of healthy balance sheet supporting growth CAPEX and potential acquisitions. - Management anticipates growth CAPEX within next 5-6 quarters to support capacity expansion.

The transcript does not provide specific details on the current or expected order book or pending orders for Apcotex Industries Limited. However, relevant insights include: - The company is experiencing strong volume growth and increased capacity utilization (Nitrile Latex plant utilization over 75% as of Dec 2024). - Export volumes grew by approximately 30% year-on-year, indicating robust demand. - They expect revenue around Rs. 1400-1450 crores for the year and potential to expand to Rs. 1700 crores with minor investments. - The company has ongoing or upcoming expansion plans with clarity expected in 3 to 6 months. - They are pursuing new product approvals and increasing customer reach, which indirectly suggests a healthy inflow of orders. - The management emphasizes strong order intake particularly in nitrile latex and other latex products, with increasing market traction in these segments. No explicit figures on orderbook or pending orders are mentioned.